We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Quality Standards for 14C API for use in human clinical studies
Poster

Quality Standards for 14C API for use in human clinical studies

Quality Standards for 14C API for use in human clinical studies
Poster

Quality Standards for 14C API for use in human clinical studies

The Good Manufacturing Practice (GMP) state that the active pharmaceutical ingredient (API) intended for use in early stage clinical trials should be of "suitable" quality. The Clinic Ready quality standard ensures that the API is synthesised with all the appropriate documentation to facilitate QP release of the final IMP for guman clinical dosing.

Advertisement